Avatar acceptability: views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisions.
Laura K FawcettClaire E WakefieldSheila SivamPeter Gordon MiddletonPeter A B WarkJohn WidgerAdam JaffeShafagh A WatersPublished in: ERJ open research (2021)
These findings indicate acceptance of patient-derived organoids as a tool to predict treatment response by the majority of people surveyed. This may indicate successful future implementation into healthcare systems.